Adaptin Bio, Inc.
APTN
$6.27
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.56% | 26.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.93% | -16.36% | |||
| Operating Income | -4.93% | 16.36% | |||
| Income Before Tax | -5.17% | 16.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.17% | 16.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.17% | 16.22% | |||
| EBIT | -4.93% | 16.36% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -3.42% | 18.35% | |||
| Normalized Basic EPS | -3.40% | 18.35% | |||
| EPS Diluted | -6.30% | 18.65% | |||
| Normalized Diluted EPS | -3.40% | 18.35% | |||
| Average Basic Shares Outstanding | 1.70% | 2.58% | |||
| Average Diluted Shares Outstanding | 1.70% | 2.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||